Trying to Find the Answers: Eric Lefkofsky

Eric Lefkofsky is much more than a teacher and philanthropist. He is the co-founder and CEO of a company named Tempus. Tempus is a company that takes patient data and uses it to help try to find patterns in diseases like cancer and the like. Tempus uses its own system in order to look at the data and help figure out the genomic sequences used in how cancer spreads through the body. By using such data doctors can create therapies for each individual patient depending on the type of cancer that they have. In an article for the Alive newspaper, Eric Lefkofsky why using data is so important when it comes to battling cancer.

How does the CEO of Tempus go about figuring out the complexities of cancer? Eric Lefkofsky’s answer is a simple and direct one. the answer for him is information. Bey combining forces Eric Lefofksy’s Tempus and other healthcare companies can use the information at hand to figure out what makes cancer tick and how to create a personal treatment for each individual. By using the information from patients and the latest analysis of molecular data, doctors can learn about treatments that have worked for patients and help break through the cancer barrier. Lefkofsky hopes that by sharing data with other companies a more effective approach can be taken when it comes to cancer treatment and care.

Eric Lefkofsky doesn’t want to stop at just cancer. He wants to give the doctors of the future a leg up when it comes to treatment and personalized medicine. He hopes in the coming years that the data and analysis methods used in cancer research can be used for other diseases as well. With the help of current gene therapies as well as patient information can help with neurological problems and not just cancer care.

Eric Lefkofsky is well on his way with his team at Tepus to tackling the problem of cancer in today’s society. He believes that information is the key to unlocking the mystery of cancer. He will keep pressing forward until the right answer is found.

Read More:

Eric Lefkofsky Startup Tempus, On Improving Cancer Treatments

Tempus CEO and philanthropist have been in the line of improving data management of Cancer through technology, a venture that was more than necessary. The billionaire was recently captioned saying that he is willing to invest over $100 million in Tempus to realize its mission. Tempus Company is focused on saving the lives of cancer patients through customized cancer treatments using genomic sequencing.

Tempus has raised a total funding of $130 million since it began in the year 2015. The current estimate valuation of Tempus is said to be at approximately $700 million though Eric Lefkofsky has not confirmed this information. Co-founder Brad Keywell and Lefkofsky remain the largest individual investors in Tempus. The company continues to add on investors and also receives funding New Enterprise Associates and Revolution Growth. The loss of a loved one motivated Lefkofsky venture into health. Tempus has so far made partnerships with the Mayo Clinic, The Cleveland Clinic, and the Duke University School of Medicine among others.

Eric Lefkosky has founded and co-founded some successful companies. Among his currently trading corporations are Echo Global Logistics, MediaBank, and the new Tempus. Among the groups that have made tremendous success include which was announced as the fastest growing company by Forbes. Eric still maintains his position as the Chairman of after stepping down as CEO.

Lefkofsky is on the board of directors of various institutions which include The Art institution of Chicago, The Museum of Science and Industry, Children Memorial Hospital and World Business Chicago. He is also a trustee of Steppenwolf Theater Company. He was also involved in the committee that was responsible for the 206 summer Olympics in Chicago. Lefkofsky has also been involved in philanthropic work. In 2006, He, together with His wife Elizabeth founded The Lefkofsky foundation which primary focus is on children. The foundation has funded over 50 organizations so far and continued to so. The Lefkofskys also joined the Giving Pledge in 2013. Lefkofsky hopes to help in saving for more cancer patients through Tempus. He is positive about the company moving its agenda on a global scale.